[go: up one dir, main page]

ITRM930356A0 - Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. - Google Patents

Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.

Info

Publication number
ITRM930356A0
ITRM930356A0 IT93RM356A ITRM930356A ITRM930356A0 IT RM930356 A0 ITRM930356 A0 IT RM930356A0 IT 93RM356 A IT93RM356 A IT 93RM356A IT RM930356 A ITRM930356 A IT RM930356A IT RM930356 A0 ITRM930356 A0 IT RM930356A0
Authority
IT
Italy
Prior art keywords
carnitine
hydroxyl
esters
treatment
pharmaceutical compositions
Prior art date
Application number
IT93RM356A
Other languages
English (en)
Inventor
Claudio Cavazza
Paolo Cavazza
Original Assignee
Avantgarde Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantgarde Spa filed Critical Avantgarde Spa
Publication of ITRM930356A0 publication Critical patent/ITRM930356A0/it
Priority to ITRM930356A priority Critical patent/IT1261688B/it
Priority to EP94108015A priority patent/EP0628309B1/en
Priority to ES94108015T priority patent/ES2130304T3/es
Priority to AT94108015T priority patent/ATE177947T1/de
Priority to DE69417290T priority patent/DE69417290T2/de
Priority to DK94108015T priority patent/DK0628309T3/da
Priority to CA002124402A priority patent/CA2124402A1/en
Priority to ZA943727A priority patent/ZA943727B/xx
Priority to JP6115025A priority patent/JPH0748328A/ja
Priority to US08/250,686 priority patent/US5494924A/en
Priority to TW083105639A priority patent/TW288976B/zh
Publication of ITRM930356A1 publication Critical patent/ITRM930356A1/it
Application granted granted Critical
Publication of IT1261688B publication Critical patent/IT1261688B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
ITRM930356A 1993-05-28 1993-05-28 Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. IT1261688B (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ITRM930356A IT1261688B (it) 1993-05-28 1993-05-28 Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
EP94108015A EP0628309B1 (en) 1993-05-28 1994-05-25 Use of O-esters of L-carnitine for the treatment of dermatoses
ES94108015T ES2130304T3 (es) 1993-05-28 1994-05-25 Empleo de o-esteres de l-carnitina para el tratamiento de dermatosis.
AT94108015T ATE177947T1 (de) 1993-05-28 1994-05-25 Verwendung von l-carnitin-o-estern zur behandlung der dermatosen
DE69417290T DE69417290T2 (de) 1993-05-28 1994-05-25 Verwendung von L-Carnitin-O-Estern zur Behandlung der Dermatosen
DK94108015T DK0628309T3 (da) 1993-05-28 1994-05-25 Anvendelse af O-estere af L-carnitin til behandling af dermatoser
CA002124402A CA2124402A1 (en) 1993-05-28 1994-05-26 Use of o-esters of l-carnitine for producing pharmaceutical compositions for the treatment of dermatoses
ZA943727A ZA943727B (en) 1993-05-28 1994-05-26 Use of o-esters of l-carnitine for producing pharmaceutical compositions for the reatment of dermatoses
JP6115025A JPH0748328A (ja) 1993-05-28 1994-05-27 Ｌ−カルニチンのｏ−エステル類を含む皮膚病処置のための医薬組成物
US08/250,686 US5494924A (en) 1993-05-28 1994-05-27 Therapeutical method for the treatment of dermatoses using O-esters of L-carnitine
TW083105639A TW288976B (it) 1993-05-28 1994-06-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930356A IT1261688B (it) 1993-05-28 1993-05-28 Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.

Publications (3)

Publication Number Publication Date
ITRM930356A0 true ITRM930356A0 (it) 1993-05-28
ITRM930356A1 ITRM930356A1 (it) 1994-11-28
IT1261688B IT1261688B (it) 1996-05-29

Family

ID=11401786

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM930356A IT1261688B (it) 1993-05-28 1993-05-28 Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.

Country Status (11)

Country Link
US (1) US5494924A (it)
EP (1) EP0628309B1 (it)
JP (1) JPH0748328A (it)
AT (1) ATE177947T1 (it)
CA (1) CA2124402A1 (it)
DE (1) DE69417290T2 (it)
DK (1) DK0628309T3 (it)
ES (1) ES2130304T3 (it)
IT (1) IT1261688B (it)
TW (1) TW288976B (it)
ZA (1) ZA943727B (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
US5667791A (en) * 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition
NZ335495A (en) 1996-11-12 2002-03-28 Dov Tamarkin alpha,omega-dicarboxylic acid esters and their use in treating dermatological disorders
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
IT1291126B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine
IT1291133B1 (it) * 1997-04-07 1998-12-29 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio tartrato
IT1291134B1 (it) 1997-04-08 1998-12-29 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti una alcanoil l-carnitina magnesio citrato
IT1291143B1 (it) * 1997-04-18 1998-12-29 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti l-carnitina colina tartrato o una alcanoil l-carnitina colina
IT1290600B1 (it) * 1997-04-30 1998-12-10 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio fumarato
US6138683A (en) * 1997-09-19 2000-10-31 Thione International, Inc. Smokeless tobacco products containing antioxidants
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
US5922346A (en) * 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
ATE254923T1 (de) 1998-03-19 2003-12-15 Sigma Tau Ind Farmaceuti Kombinierte zusammensetzung bestehend aus l- karnitin oder l-alkanoylkarnitin, einem glycosaminoglycan und/oder einem seiner bestandteile
US6242491B1 (en) * 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US20040198821A1 (en) * 2002-01-29 2004-10-07 Hwang Cheng Shine Reduction of hair growth
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
CN1960698A (zh) * 2004-05-31 2007-05-09 昭和电工株式会社 含肉碱衍生物的局部减肥制剂和化妆品
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
US20140316156A1 (en) * 2013-04-18 2014-10-23 Deborah Warner Method of producing therapeutic agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1156840B (it) * 1978-06-27 1987-02-04 Sigma Tau Ind Farmaceuti Acil derivati della carnitina
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
FR2654619B1 (fr) * 1989-11-23 1992-01-31 Sederma Sa Utilisation en cosmetique de composes destines a optimiser la penetration des principes actifs.
IT1263013B (it) * 1992-10-20 1996-07-23 Avantgarde Spa Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee.

Also Published As

Publication number Publication date
ATE177947T1 (de) 1999-04-15
JPH0748328A (ja) 1995-02-21
IT1261688B (it) 1996-05-29
EP0628309B1 (en) 1999-03-24
DE69417290T2 (de) 1999-08-19
ZA943727B (en) 1995-02-02
TW288976B (it) 1996-10-21
CA2124402A1 (en) 1994-11-29
ES2130304T3 (es) 1999-07-01
ITRM930356A1 (it) 1994-11-28
EP0628309A1 (en) 1994-12-14
DE69417290D1 (de) 1999-04-29
DK0628309T3 (da) 1999-10-11
US5494924A (en) 1996-02-27

Similar Documents

Publication Publication Date Title
ITRM930356A0 (it) Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
ITRM930399A0 (it) Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
ITRM920761A0 (it) Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee.
FI980822A7 (fi) Farmaseuttinen koostumus vaikuttavan aineen iho- tai limakalvopintaan tai iho- tai limakalvopinnan läpi
IT1272290B (it) Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
ITMI981586A0 (it) Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
ITRM930365A0 (it) Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.
ITRM910327A0 (it) Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie.
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
IT1274157B (it) "sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee"
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
FI904475A7 (fi) Tymopentiiniä sisältävät koostumukset ihosairauksien hoitamiseksi paik allisesti
ITMI950958A0 (it) Composizioni farmaceutiche per il trattamento della alcol-dipendenza
DE68908414D1 (de) Pharmazeutische zusammensetzungen fuer die reizung eines immunostimulierenden effektes.
CA2075926A1 (en) Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them
IT1204571B (it) Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato,loro procedimento di preparazione e loro composizioni farmaceutiche
ITRM950589A0 (it) Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire malattie causate dalla sovrapproduzione di dette citochine naturali, e composizioni farmaceutiche cosi' ottenibili
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
EP0302303A3 (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
IT1248983B (it) Procedimento per la sintesi di alfa-idrossi esteri
AU1002697A (en) Topical compositions for the treatment of skin disease
ITMI911206A0 (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970418